Multiparametric Integrated 18F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding
Lale Umutlu(Essen University Hospital), Katja Pinker(Medical University of Vienna), Nils Martin Bruckmann(Heinrich Heine University Düsseldorf), Ken Herrmann(Essen University Hospital), Janna Morawitz(Heinrich Heine University Düsseldorf), Johannes Haubold(Essen University Hospital), Christoph Rischpler(Essen University Hospital), Gerald Antoch(Heinrich Heine University Düsseldorf), Harald H. Quick(Erwin L. Hahn Institute for Magnetic Resonance Imaging), Johannes Grueneisen(Ihre-Radiologen), Ann‐Kathrin Bittner(University of Duisburg-Essen), Oliver Hoffmann(University of Duisburg-Essen), Marc Ingenwerth(Deutschen Konsortium für Translationale Krebsforschung), Peter Gibbs(Memorial Sloan Kettering Cancer Center), Julian Kirchner(Düsseldorf University Hospital)
Cited by 51
Related Papers
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
|The Lancet Oncology|2007|808
Metabolic Imaging Predicts Response, Survival, and Recurrence in Adenocarcinomas of the Esophagogastric Junction
|Journal of Clinical Oncology|2006|464
Radiotheranostics: a roadmap for future development
|The Lancet Oncology|2020|306